Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisis
Bin Zhang,Dandan Zhao,Fang Chen,David Frankhouser,Huafeng Wang,Khyatiben V. Pathak,Lei Dong,Anakaren Torres,Krystine Garcia-Mansfield,Yi Zhang,Dinh Hoa Hoang,Min-Hsuan Chen,Shu Tao,Hyejin Cho,Yong Liang,Danilo Perrotti,Sergio Branciamore,Russell Rockne,Xiwei Wu,Lucy Ghoda,Ling Li,Jie Jin,Jianjun Chen,Jianhua Yu,Michael A. Caligiuri,Ya-Huei Kuo,Mark Boldin,Rui Su,Piotr Swiderski,Marcin Kortylewski,Patrick Pirrotte,Le Xuan Truong Nguyen,Guido Marcucci
DOI: https://doi.org/10.1038/s41467-023-41167-z
IF: 16.6
2023-09-02
Nature Communications
Abstract:The mechanisms underlying the transformation of chronic myeloid leukemia (CML) from chronic phase (CP) to blast crisis (BC) are not fully elucidated. Here, we show lower levels of miR-142 in CD34 + CD38 − blasts from BC CML patients than in those from CP CML patients, suggesting that miR-142 deficit is implicated in BC evolution. Thus, we create miR-142 knockout CML (i.e., miR-142 −/− BCR-ABL ) mice, which develop BC and die sooner than miR-142 wt CML (i.e., miR-142 +/+ BCR-ABL ) mice, which instead remain in CP CML. Leukemic stem cells (LSCs) from miR-142 −/− BCR-ABL mice recapitulate the BC phenotype in congenic recipients, supporting LSC transformation by miR-142 deficit. State-transition and mutual information analyses of "bulk" and single cell RNA-seq data, metabolomic profiling and functional metabolic assays identify enhanced fatty acid β-oxidation, oxidative phosphorylation and mitochondrial fusion in LSCs as key steps in miR-142-driven BC evolution. A synthetic CpG-miR-142 mimic oligodeoxynucleotide rescues the BC phenotype in miR-142 −/− BCR-ABL mice and patient-derived xenografts.
multidisciplinary sciences